Minireviews
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Aug 15, 2020; 12(8): 850-856
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.850
Gastric neuroendocrine tumor: A practical literature review
Gabriel Antonio Roberto, Carolina Magalhães Britto Rodrigues, Renata D’Alpino Peixoto, Riad Naim Younes
Gabriel Antonio Roberto, Carolina Magalhães Britto Rodrigues, Bachelor Medicine, União das Faculdades dos Grandes Lagos, São José do Rio Preto 15030070, Brazil
Renata D’Alpino Peixoto, Department of Oncology, Hospital Alemão Oswaldo Cruz, São Paulo 01327001, Brazil
Renata D’Alpino Peixoto, Universidade Nove de Julho, São Paulo 01327001, Brazil
Riad Naim Younes, Department of Thoracic Surgery, Hospital Alemão Oswaldo Cruz, São Paulo 01327001, Brazil
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Gabriel Antonio Roberto, BM BCh, Bmed, Academic Research, Bachelor Medicine, União das Faculdades dos Grandes Lagos, Rua Dr. Eduardo Nielsem, 960 Jd. N. Aeroporto, São Jose do Rio Preto 15030070, Brazil. contatogabrielroberto@gmail.com
Received: March 20, 2020
Peer-review started: March 20, 2020
First decision: April 26, 2020
Revised: May 5, 2020
Accepted: July 19, 2020
Article in press: July 19, 2020
Published online: August 15, 2020
Processing time: 145 Days and 8.9 Hours
Core Tip

Core tip: Gastric neuroendocrine tumors are rare lesions that are part of the gastroenteropancreatic neuroendocrine tumors group. They are classified into types I, II and III according to their clinical and pathophysiological characteristics. Their diagnosis is usually made incidentally by upper gastrointestinal endoscopy, and most cases are treated by endoscopic resection. Surgical resections, as well as somatostatin analog treatments, are reserved for selected cases. Although rare, gastric neuroendocrine tumors need further research as their incidence has increased over the years.